× Medicines Discovery Catapult

We’re providing updates on the COVID-19 situation for the UK drug discovery community. Our aim is to help the community during this challenging time and also highlight important work and resources.

MDC update

Medicines Discovery Catapult (MDC) is doing all we can to maintain business continuity with minimal disruption to our employees, collaboration partners and suppliers.

We are fully committed to the successful completion of our projects together, working with the community during this time of national need.

UK Lighthouse Labs launched: Medicines Discovery Catapult, in partnership with industry and academia, advancing COVID-19 testing capacity

Visit the UK Lighthouse Labs Network website >

Support from across the community

“We are delighted to see that Alderley Park has been designated as a national testing centre. This will allow the University of Manchester to build on our already strong partnership with Alderley Park to deliver fast and effective testing, as part of our wider contribution to tackling Covid-19.”

Professor Dame Nancy Rothwell, FRS, FRSB, FMedSci,  President & Vice-Chancellor, Professor of Physiology, University of Manchester

“The life sciences sector across the North of England is working hard to combat COVID-19 with new tests, treatments and vaccines already under development. The regional COVID-19 testing centre at Alderley Park coordinated by the Medicines Discovery Catapult represents an essential step forward in scaling up the UK’s coordinated national ability to track and combat this disease. Bionow members have come forward in their droves to support this initiative and will be central partners in delivering it successfully.”

Dr John Stageman OBE, Chairman of Bionow & LifeArc

“Manchester Metropolitan University is proud to be supporting this national and regional effort to provide key expertise to the formation of the North West COVID-19 screening facility. Through partnerships across the North West, together I am sure we can support the national effort to help to combat the pandemic.”

Professor Steve Decent, Provost and Deputy Vice-Chancellor, Manchester Metropolitan University

“The University of Manchester in concert with other North West Universities strongly believes that the most efficient and safe way to achieve test capacity increase is to support with equipment, consumables and most importantly volunteer staff, the establishment of a single high throughput facility for COVID-19 testing for the North West of England. The Alderley Park Facility will allow us to rapidly and safely ramp up test capacity. As the World Health Organisation Head Dr Tedros Adhanom Ghebreyesus has stated the key message must be: test, test, test.”

Professor Paul Klapper, Clinical Virology, University of Manchester

“Alderley Park is an outstanding facility for Life Science work, it has top quality, large scale, laboratory facilities, a great management team, access to high quality talent and a connected location.  In the current crisis it makes absolute sense for these facilities to be used immediately as a hub for testing, and as a home for future diagnostic work both for the private and  public sector.”

Chris Brinsmead CBE (ex Co-Chair of the Alderley Park task force)